23 studies found for:    "Splenomegaly"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Withdrawn Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly
Conditions: Hyper-reactive Malarial Splenomegaly;   Malaria;   Anaemia
Interventions: Drug: prednisone induction - chloroquine;   Drug: Chloroquine
2 Not yet recruiting A Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
Conditions: Leukemia;   Myelofibrosis;   Anemia;   Splenomegaly
Interventions: Drug: Rigosertib;   Behavioral: Questionnaire
3 Completed
Has Results
Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination
Conditions: Splenomegaly;   Pleural Effusion
Intervention: Device: resident with GE vscan
4 Completed Estimation of Spleen by Residents With VScan
Condition: Splenomegaly
Intervention: Device: VScan Ultrasound (GE Healthcare, USA)
5 Completed Ultrasound Estimation of Spleen Size
Condition: Splenomegaly
Interventions: Device: Vscan Ultrasound (GE Healthcare, USA);   Device: Conventional Ultrasound
6 Completed Spleen Size in Peripheral Blood Stem Cell Donors
Condition: Splenomegaly
Intervention:
7 Not yet recruiting The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department
Conditions: Infectious Mononucleosis;   Splenomegaly
Intervention: Device: Point-of-care ultrasound
8 Recruiting CINC424A2X01B Rollover Protocol
Condition: Splenomegaly
Intervention: Drug: Ruxolitinib
9 Unknown  Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
Conditions: Liver Cirrhosis;   Carcinoma, Hepatocellular;   Splenomegaly;   Laparotomy
Intervention:
10 Completed Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly
Condition: Myelofibrosis
Intervention: Drug: SAR302503
11 Recruiting The Treatment of Hepatocirrhosis and Portal Hypertension
Condition: Hepatic Cirrhosis
Intervention: Procedure: PSE
12 Completed Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Condition: Hematopoietic Neoplasm
Interventions: Drug: SAR302503;   Drug: Placebo
13 Completed Phase 2 Study of SAR302503 in Patients With Myelofibrosis
Condition: Hematopoietic Neoplasm
Intervention: Drug: SAR302503
14 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
Intervention:
15 Active, not recruiting Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
Conditions: Primary Myelofibrosis;   Post-polycythemia Vera Myelofibrosis;   Post-essential Thrombocythemia Myelofibrosis
Interventions: Drug: Pacritinib;   Drug: Best Available Therapy
16 Active, not recruiting Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis
Conditions: Primary Myelofibrosis;   Post-polycythemia Vera Myelofibrosis;   Post-essential Thrombocythemia Myelofibrosis
Interventions: Drug: Pacritinib;   Drug: Best Available Therapy
17 No longer available Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
Condition: Gaucher Disease
Intervention: Drug: Plant cell expressed recombinant glucocerebrosidase (prGCD)
18 Completed Prospective Randomized Comparison of Clinical Results of Hand Assisted Laparoscopic Splenectomies and Open Splenectomies
Condition: Postoperative Pain
Intervention:
19 Completed
Has Results
Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: ALPS;   Hypersplenism;   Lymphadenopathy
Interventions: Drug: Valproic Acid;   Procedure: CT Scan;   Procedure: Blood Sample
20 Completed Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder
Intervention: Drug: Pyrimethamine

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years